Serological Assays for the Detection and Characterization of Influenza Viruses

Location:	Georgia
Posted:	Dec 11, 2025
Due:	Feb 15, 2026
Agency:	HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Government:	Federal
Category:	Q - Medical Services
Solicitation No:	75D30125R73235
Publication URL:	To access bid details, please log in.

Active

Contract Opportunity

Notice ID

75D30125R73235

Related Notice

Department/Ind. Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier

CENTERS FOR DISEASE CONTROL AND PREVENTION

Office

CDC OFFICE OF ACQUISITION SERVICES

Looking for contract opportunity help?

(opens in new window)

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes

Contract Opportunity Type: Solicitation (Updated)
Updated Published Date: Dec 11, 2025 03:04 pm EST
Original Published Date: Jan 16, 2025 05:46 pm EST
Updated Date Offers Due: Feb 15, 2026 02:00 pm EST
Original Date Offers Due: Feb 07, 2025 02:00 pm EST
Inactive Policy: Manual
Updated Inactive Date: Dec 15, 2026
Original Inactive Date: May 15, 2025
Initiative:
- None

Classification

Original Set Aside:
Product Service Code: Q301 - REFERENCE LABORATORY TESTING
NAICS Code:
- 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance:
Atlanta , GA

USA

Description View Changes

Amendment 5 is being issued to re-open the solicitation and proceed with source selection activities. Reinstate Jennifer Gartzke as the point of contact. The attached SF30 contains additional information.

Attachments/Links

Contact Information

Contracting Office Address

1600 CLIFTON ROAD
ATLANTA , GA 30333
USA

Primary Point of Contact

Jennifer Gartzke
jgartzke@cdc.gov

Secondary Point of Contact

History

Dec 11, 2025 03:04 pm ESTSolicitation (Updated)
Dec 11, 2025 03:00 pm EST Solicitation (Updated)
Oct 30, 2025 11:55 pm EDT Solicitation (Updated)
Mar 26, 2025 10:18 am EDT Solicitation (Updated)
Mar 18, 2025 02:27 pm EDT Solicitation (Updated)
Feb 19, 2025 05:39 pm EST Solicitation (Updated)
Jan 16, 2025 05:46 pm EST Solicitation (Original)

Jan 16, 2025	[Solicitation (Original)] Serological Assays for the Detection and Characterization of Influenza Viruses
Feb 19, 2025	[Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses
Mar 18, 2025	[Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses
Mar 27, 2025	[Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses
Apr 15, 2025	[Solicitation (Updated)] Serological Assays for the Detection and Characterization of Influenza Viruses

Serological Assays for the Detection and Characterization of Influenza Viruses

Related Document

See also